Opaleye Management’s Obsidian Therapeutics OBX Stock Holding History
Bought
Maintained
Sold
Other funds holding OBX
Opaleye Management's OBX Position: Q3 2026 in Review
Opaleye Management opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 75,755 shares worth $1.04M. The stake represents 0.12% of the portfolio and ranks #54 among its holdings.
61 funds tracked by Wall St. Rank hold OBX as of Q3 2026.
- Opaleye Management held 75,755 shares of Obsidian Therapeutics worth $1.04M as of Q3 2026.
- Obsidian Therapeutics was a new Opaleye Management position in Q3 2026.
- Obsidian Therapeutics made up 0.12% of Opaleye Management's portfolio in Q3 2026, its #54 holding.
- 61 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.
Based on Opaleye Management's 13F filing for Q3 2026, filed 16 Nov 2026.